IP Library › Granted Patent US 11,596,616
Granted Patent B2
US 11,596,616 · App. 16/772,490 · Granted Mar 7, 2023

Compositions and methods for weight loss maintenance

Inventors: Dominic Paul D'Agostino (Tampa, FL); Angela Marie Poff (Tampa, FL); Andrew Paul Koutnik (Tampa, FL)
Assignee: UNIVERSITY OF SOUTH FLORIDA
A61K31/22A23L33/10A23L33/30A61K9/0056A61K31/19A61P3/04A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,596,616
App. No.
16/772,490
Granted
Mar 7, 2023
Kind
B2
Abstract

Compositions and methods for inducing weight loss, fat loss, maintaining weight or fat loss, suppressing appetite, reducing calorie intake, reducing weight gain, decreasing feed efficiency, increasing metabolic inefficiency, increasing energy expenditure, increasing thermogenesis and/or resetting metabolic set are disclosed. The compositions have a therapeutically effective amount of a ketogenic supplement, e.g., a ketone diesters, such as R,S 1,3-butanediol diacetoacetate. Compositions of one or more beta-hydroxybutyrate, beta-hydroxybutyrate salt, and medium chain triglycerides are also disclosed.

Claims (21)

1. A composition comprising:

R,S 1,3-butanediol diacetoacetate diester in a therapeutically effective amount to induce weight loss, induce fat loss, and/or maintain the weight or fat loss, and a pharmaceutically acceptable carrier,

wherein the composition is a food with about 10-30% by weight R,S 1,3-butanediol diacetoacetate diester.

2. The composition of claim 1 , wherein the composition further comprises one or more beta-hydroxybutyrate, beta-hydroxybutyrate salt, or medium chain triglycerides.

3. A composition comprising:

R,S 1,3-butanediol diacetoacetate diester in a therapeutically effective amount to suppress appetite, reduce calorie intake, or reduce weight gain, and a pharmaceutically acceptable carrier,

wherein the composition is a food with about 10-30% by weight R,S 1,3-butanediol diacetoacetate diester.

4. A composition comprising:

R,S 1,3-butanediol diacetoacetate diester in a therapeutically effective amount to decrease feed efficiency, increase metabolic inefficiency, increase energy expenditure, increase thermogenesis and/or reset metabolic set point, and a pharmaceutically acceptable carrier,

wherein the composition is a food with about 10-30% by weight R,S 1,3-butanediol diacetoacetate diester.

5. The composition of claim 1 , wherein the food is a snack food, nutritional bar, protein bar, or beverage.

6. The composition of claim 1 , wherein the pharmaceutically acceptable carrier is a liquid pharmaceutical carrier comprising water, milk, or juice.

7. The composition of claim 1 , wherein the composition has from 0.5 to 300 g of R,S 1,3-butanediol diacetoacetate diester.

8. The composition of claim 3 , wherein the food is a snack food, nutritional bar, protein bar, or beverage.

9. The composition of claim 3 , wherein the pharmaceutically acceptable carrier is a liquid pharmaceutical carrier comprising water, milk, or juice.

10. The composition of claim 3 , wherein the composition has from 0.5 to 300 g of R,S 1,3-butanediol diacetoacetate diester.

11. The composition of claim 3 , wherein the composition further comprises one or more beta-hydroxybutyrate, beta-hydroxybutyrate salt, or medium chain triglycerides.

12. The composition of claim 4 , wherein the food is a snack food, nutritional bar, protein bar, or beverage.

13. The composition of claim 4 , wherein the pharmaceutically acceptable carrier is a liquid pharmaceutical carrier comprising water, milk, or juice.

14. The composition of claim 4 , wherein the composition has from 0.5 to 300 g of R,S 1,3-butanediol diacetoacetate diester.

15. The composition of claim 4 , wherein the composition further comprises one or more beta-hydroxybutyrate, beta-hydroxybutyrate salt, or medium chain triglycerides.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 22, 2021
From: D'AGOSTINO, DOMINIC PAUL; POFF, ANGELA MARIE; KOUTNIK, ANDREW PAUL
To: UNIVERSITY OF SOUTH FLORIDA
Reel/Frame 055670/0679 →
Continuity (3)
Provisional Application 62597640 · Dec 12, 2017
Provisional Application 62630492 · Feb 14, 2018
Related Publication 20200397736A1 · Dec 24, 2020
Cited By (1)
US 12,310,938